SerbinCommunications

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbin.com LA / NY / UK

Cidofovir versus Brincidofovir (oral antiviral) 

Prev Next
Previous

FluMist® Quadrivalent vs Wild Flu Antigens

medical illustration of Drug's mechanism of action graphics at cellular level for pharmaceutical project, explaining how Chimerix’s novel oral antiviral, Brincidofovir, has enhanced intracellular uptake compared to Cidofovir. Brincidofovir has a monoacyl lipid side chain that enables it to rapidly enter by flip-flopping. Keywords: molecular biology, cellular biology, histology, pharmacology, virology, disease management
Next medical illustration of Cellular level discussion of multiple sclerosis disease state — used as booth graphics for therapeutic monoclonal antibody Daclizumab (Zenapax®). 
Part of a series; Drug's mechanism of action graphics at cellular level for pharmaceutical project.

The Role of IL-2 in Multiple Sclerosis

Drug's mechanism of action graphics at cellular level for pharmaceutical project, explaining how Chimerix’s novel oral antiviral, Brincidofovir, has enhanced intracellular uptake compared to Cidofovir. Brincidofovir has a monoacyl lipid side chain that enables it to rapidly enter by flip-flopping. Keywords: molecular biology, cellular biology, histology, pharmacology, virology, disease management

Keywords: Advertising / Marketing, Allergy / Immunology, Biology, Biotechnology, Cell biology / Histology, Disease Management, Endocrinology / Metabolic, Molecular Biology, Pharmacology, Virology

© Mica Duran